跳至主要内容
临床试验/NCT04026438
NCT04026438已完成4 期

Randomized Controlled Trial to Study the Outcome of Intravenous Phosphate Supplementation in Live Donors Undergoing Hepatectomy for Living Donor Liver Transplantation (LDLT)

Institute of Liver and Biliary Sciences, India1 个研究点 分布在 1 个国家目标入组 130 人开始时间: 2019年1月21日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
130
试验地点
1
主要终点
Post operative complications

研究概览

简要总结

In this study, we aim to analyse the effect of phosphate supplementation on donors undergoing partial hepatectomy for LDLT. In Group A, we are going to supplement phosphate in donors postoperatively from day 1 to day 5. We will analyse the trend of serum phosphate levels in donors postoperatively, its correlation with occurrence of postoperative complications and status of liver regeneration by CT volumetry on Day 7. Group B will constitute the controls for the study and hence attempt to find out the effect of phosphate supplementation in all donors postoperatively. We will analyse the data and elucidate the value of phosphate supplementation in reducing the occurrence of complications and effect on liver regeneration in donors in LDLT.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 50 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • All donors evaluated as per institutional protocol for donor hepatectomy and found fit
  • Those who consent.

排除标准

  • Patients refusing to consent for inclusion in the study.
  • Minor hepatectomy
  • Those who develop profound hypophosphatemia in the control group

研究组 & 干预措施

Intervention Arm - potassium phosphate injection

Experimental

干预措施: Potassium Phosphate Injection (Drug)

结局指标

主要结局

Post operative complications

时间窗: 1 month

Outcome of phosphate supplementation in reducing the occurrence of postoperative complications assessed by Clavien Dindo grading

次要结局

  • Trend of serum phosphorous levels(1 week)
  • Duration of hospital, ICU stay(Till patient is discharged on an average of 10 days)
  • Trends in post-operative liver function tests(1 week)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Vivek Rajendran

Senior Resident, Department of HPB surgery and liver transplantation

Institute of Liver and Biliary Sciences, India

研究点 (1)

Loading locations...

相似试验